Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

11 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Clonally expanded PD-1-expressing T cells are enriched in synovial fluid of juvenile idiopathic arthritis patients.
Vanni A, Mazzoni A, Semeraro R, Capone M, Maschmeyer P, Lamacchia G, Salvati L, Carnasciali A, Farahvachi P, Giani T, Simonini G, Filocamo G, Romano M, Liotta F, Mashreghi MF, Cosmi L, Cimaz R, Magi A, Maggi L, Annunziato F. Vanni A, et al. Among authors: carnasciali a. Eur J Immunol. 2023 Jul;53(7):e2250162. doi: 10.1002/eji.202250162. Epub 2023 May 8. Eur J Immunol. 2023. PMID: 37086046 Free article.
SARS-CoV-2 Spike-Specific CD4+ T Cell Response Is Conserved Against Variants of Concern, Including Omicron.
Mazzoni A, Vanni A, Spinicci M, Capone M, Lamacchia G, Salvati L, Coppi M, Antonelli A, Carnasciali A, Farahvachi P, Giovacchini N, Aiezza N, Malentacchi F, Zammarchi L, Liotta F, Rossolini GM, Bartoloni A, Cosmi L, Maggi L, Annunziato F. Mazzoni A, et al. Among authors: carnasciali a. Front Immunol. 2022 Jan 26;13:801431. doi: 10.3389/fimmu.2022.801431. eCollection 2022. Front Immunol. 2022. PMID: 35154116 Free PMC article.
Clinical and Immunological Features of SARS-CoV-2 Breakthrough Infections in Vaccinated Individuals Requiring Hospitalization.
Lamacchia G, Mazzoni A, Spinicci M, Vanni A, Salvati L, Peruzzi B, Bencini S, Capone M, Carnasciali A, Farahvachi P, Rocca A, Kiros ST, Graziani L, Zammarchi L, Mencarini J, Colao MG, Caporale R, Liotta F, Cosmi L, Rossolini GM, Bartoloni A, Maggi L, Annunziato F. Lamacchia G, et al. Among authors: carnasciali a. J Clin Immunol. 2022 Oct;42(7):1379-1391. doi: 10.1007/s10875-022-01325-2. Epub 2022 Jul 9. J Clin Immunol. 2022. PMID: 35809212 Free PMC article.
SARS-CoV-2 infection and vaccination trigger long-lived B and CD4+ T lymphocytes with implications for booster strategies.
Mazzoni A, Vanni A, Spinicci M, Lamacchia G, Kiros ST, Rocca A, Capone M, Di Lauria N, Salvati L, Carnasciali A, Mantengoli E, Farahvachi P, Zammarchi L, Lagi F, Colao MG, Liotta F, Cosmi L, Maggi L, Bartoloni A, Rossolini GM, Annunziato F. Mazzoni A, et al. Among authors: carnasciali a. J Clin Invest. 2022 Mar 15;132(6):e157990. doi: 10.1172/JCI157990. J Clin Invest. 2022. PMID: 35139036 Free PMC article.
Fourth Dose of mRNA COVID-19 Vaccine Transiently Reactivates Spike-Specific Immunological Memory in People Living with HIV (PLWH).
Lamacchia G, Salvati L, Kiros ST, Mazzoni A, Vanni A, Capone M, Carnasciali A, Farahvachi P, Lagi F, Di Lauria N, Rocca A, Colao MG, Liotta F, Cosmi L, Rossolini GM, Bartoloni A, Maggi L, Annunziato F. Lamacchia G, et al. Among authors: carnasciali a. Biomedicines. 2022 Dec 15;10(12):3261. doi: 10.3390/biomedicines10123261. Biomedicines. 2022. PMID: 36552017 Free PMC article.
Musculin does not modulate the disease course of Experimental Autoimmune Encephalomyelitis and DSS colitis.
Vanni A, Carnasciali A, Mazzoni A, Russo E, Farahvachi P, Gloria LD, Ramazzotti M, Lamacchia G, Capone M, Salvati L, Calosi L, Bani D, Liotta F, Cosmi L, Amedei A, Ballerini C, Maggi L, Annunziato F. Vanni A, et al. Among authors: carnasciali a. Immunol Lett. 2023 Mar;255:21-31. doi: 10.1016/j.imlet.2023.02.006. Epub 2023 Feb 26. Immunol Lett. 2023. PMID: 36848960 Free article.
Investigating Serum sHLA-G Cooperation With MRI Activity and Disease-Modifying Treatment Outcome in Relapsing-Remitting Multiple Sclerosis.
Amoriello R, Rizzo R, Mariottini A, Bortolotti D, Gentili V, Bonechi E, Aldinucci A, Carnasciali A, Peruzzi B, Repice AM, Massacesi L, Fainardi E, Ballerini C. Amoriello R, et al. Among authors: carnasciali a. Front Neurol. 2022 May 25;13:872396. doi: 10.3389/fneur.2022.872396. eCollection 2022. Front Neurol. 2022. PMID: 35693002 Free PMC article.
TCR repertoire diversity in Multiple Sclerosis: High-dimensional bioinformatics analysis of sequences from brain, cerebrospinal fluid and peripheral blood.
Amoriello R, Chernigovskaya M, Greiff V, Carnasciali A, Massacesi L, Barilaro A, Repice AM, Biagioli T, Aldinucci A, Muraro PA, Laplaud DA, Lossius A, Ballerini C. Amoriello R, et al. Among authors: carnasciali a. EBioMedicine. 2021 Jun;68:103429. doi: 10.1016/j.ebiom.2021.103429. Epub 2021 Jun 11. EBioMedicine. 2021. PMID: 34127432 Free PMC article.
11 results